Michael Croft

机构：La Jolla Institute for Immunology · ORCID：0000-0002-6062-3635

发表论文 319 篇 · 总被引 22242 次 · h-index 79

代表论文

• TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy (2021 · Science Immunology · 被引 102)
• Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer (2024 · Nature Reviews Drug Discovery · 被引 93)
• OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target (2024 · American Journal of Clinical Dermatology · 被引 84)
• Realigning the LIGHT signaling network to control dysregulated inflammation (2022 · The Journal of Experimental Medicine · 被引 58)
• The role of OX40 ligand/OX40 axis signalling in atopic dermatitis (2024 · British Journal of Dermatology · 被引 47)
• Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity (2021 · Human Genetics · 被引 42)